| Analysis | Metabolite Name | Measured Value | Units | Group |
|---|---|---|---|---|
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.2756 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.2756 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.4138 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.4446 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.4853 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.5503 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.5529 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.5587 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.6280 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.6507 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.6584 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.6637 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.6703 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.6844 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.7240 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.7291 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.7540 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.7545 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.7622 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.7661 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.7747 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.7822 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.7870 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.7955 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.7957 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.8045 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.8067 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.8204 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.8227 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.8232 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.8311 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.8390 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.8420 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.8434 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.8660 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.8665 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.8704 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.8725 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.8813 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.8817 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.8892 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.8892 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.9049 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.9262 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.9319 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.9376 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.9417 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.9763 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.9853 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 0.9928 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.0072 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.0095 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.0112 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.0136 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.0425 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.0456 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.0576 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.0894 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.0966 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.1123 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.1130 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.1252 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.1270 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.1286 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.1353 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.1367 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.1466 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.1554 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.1839 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.2161 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.2807 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.2929 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.2981 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.3436 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.3605 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.3630 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.3965 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.4125 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.4173 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.4215 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.4276 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.4284 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.4356 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.5120 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.5424 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.5920 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.6028 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.6697 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.7100 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.7503 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 1.8528 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 2.1372 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 2.2495 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 2.3201 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 2.8157 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 3.6779 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 4.3305 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 5.6607 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-oleoylglycerol (18:1) | 6.8288 | Peak area | Diabetic Neuropathy |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|